The hormones in dosage except contraceptives and antibiotics market in Tunisia showcased fluctuating trends from 2013 to 2023. In the 2023 data, the market size value stood at $1.76 per capita. Over the most recent two years, there was a decline: from 2021 to 2022, the value decreased by approximately 10.5%, and from 2022 to 2023, it dropped by around 1.68%. Looking at the five-year CAGR from 2019 to 2023, the market experienced an average annual contraction of about 1.37%. These variations indicate a shrinking market, with potential stability required in future strategies.
Future trends to watch:
- Potential regulatory changes impacting hormone products.
- Increasing healthcare awareness influencing demand dynamics.
- Technological advancements introducing new hormonal therapies.
